← Eichor
Study identifier: NCT04703166 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.

Condition: Atrial Fibrillation  ·  Sponsor: Tulane University School of Medicine

PhaseN/A
Planned participants360
Who can joinAll sexes, 18 Years to 79 Years
Healthy volunteersNo

About this study

To evaluate the progression of atrial myopathy through wearable devices and cardiac imaging.

This description comes directly from the study's public registry record.

Talk to the study team

Quintrele Jones, MPH  ·  504-988-3063  ·  qjones1@tulane.edu

Chris Wang, MS  ·  504-988-3065  ·  hwang37@tulane.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Tulane University School of MedicineNew Orleans, Louisiana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04703166